针对非小细胞肺癌罕见突变的新型治疗策略
Qitao Gou1, Qiheng Gou2, Xiaochuan Gan3
1Department of Radiation Oncology and Department of Head & Neck Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Scientific reports
|May 5, 2024
概括
分子向疗法为患有罕见遗传突变的非小细胞肺癌 (NSCLC) 患者提供了新的希望. 这些向药物为特定的瘤驱动因素提供了比传统化疗和免疫疗法更好的生存益处.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是全球癌症死亡的主要原因.
- 分子分析的进步已经确定了许多导致NSCLC的遗传异常.
- 向疗法已经彻底改变了NSCLC的治疗模式.
研究的目的:
- 审查NSCLC分子向治疗的最新进展.
- 突出新批准的药物用于NSCLC罕见的瘤驱动因素.
- 与化疗和免疫疗法相比,讨论针对性治疗的疗效.
主要方法:
- 审查最近的科学文献和临床试验数据.
- 专注于基因测序技术和罕见突变的识别.
- 分析已批准的分子向疗法及其临床结果.
主要成果:
- 识别关键的遗传异常,包括EGFR,ALK,NTRK和MET.
- 开发针对性的药物,如多酶抑制剂,用于罕见的突变.
- 在患有特定瘤驱动因素的患者中,有针对性的治疗对生存的证明.
结论:
- 分子向疗法代表了NSCLC管理的重大进步.
- 向性药物为患有罕见遗传驱动因素的患者提供了改善的结果.
- 持续的研究和开发对于扩大向治疗选择至关重要.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
7.9K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
